XML 68 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation Level 3 (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] The fair values of our stock options are calculated using the following weighted average assumptions, based on the methods described above:
Years Ended December 31,
Assumptions202120202019
Dividend yield1.8%1.7%1.7%
Expected volatility23.5%18.0%19.8%
Risk-free interest rate0.4%1.4%2.5%
Expected holding period (years)4.03.74.0
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
The following table summarizes certain information with respect to stock option and restricted share compensation included in our Consolidated Statement of Operations:
Years Ended December 31,
 202120202019
 (In thousands)
Total pretax employee share-based compensation expense included in net income$14,168 $14,103 $15,029 
Income tax benefit related to share-based compensation included in net income$3,537 $3,417 $3,842 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
The following table sets forth stock option activity for the year ended December 31, 2021 (shares reported in whole numbers):
OptionsWeighted-Average
Exercise Price
Outstanding at December 31, 20206,912,065 $32.34 
Granted652,290 $49.59 
Exercised(1,641,663)$24.17 
Outstanding at December 31, 20215,922,692 $36.50 
Exercisable at December 31, 20214,375,143 $32.10 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
Set forth below is certain information related to stock options outstanding and exercisable at December 31, 2021 (shares reported in whole numbers):
 Options OutstandingOptions Exercisable
Range of Exercise PriceNumber
Outstanding at
December 31, 2021
Weighted-Average Remaining Contractual Life
(in years)
Weighted-
Average Exercise Price
Number
Exercisable at
December 31, 2021
Weighted-
Average Exercise Price
$0.00 — 25.001,425,927 1.8$22.54 1,425,927 $22.54 
$25.01 — 35.001,087,720 3.1$29.25 1,087,720 $29.25 
$35.01 — 45.001,809,995 4.6$39.65 1,552,021 $39.16 
$45.01 — 55.001,599,050 6.5$50.32 309,475 $50.82 
$0.00 — 55.00
5,922,692 4.2$36.50 4,375,143 $32.10 
Other Information Pertaining to Stock Option Activity [Table Text Block]
Other information pertaining to stock options was as follows (in thousands, except weighted-average grant date fair value):
Years Ended December 31,
202120202019
Weighted average grant-date fair value of stock options granted$7.50 $6.44 $6.86 
Total fair value of stock options vested$5,708 $5,535 $7,250 
Total intrinsic value of stock options exercised$59,180 $41,995 $65,023 
Cash received from the exercise of stock options
$39,354 $26,671 $40,922 
Recognized compensation expense
$5,514 $5,668 $6,314 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Restricted share award activity was as follows (share awards reported in whole numbers):
Restricted
Share Awards
Weighted-Average
Grant-Date
Fair Value
Nonvested restricted share awards at December 31, 2020243,529 $45.52 
Granted113,359 $49.59 
Vested(126,978)$43.28 
Nonvested restricted share awards at December 31, 2021229,910 $48.76 
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Restricted
Share Units
Weighted-Average
Grant-Date
Fair Value
Nonvested restricted share units at December 31, 2020135,308 $43.83 
Granted65,825 $49.59 
Vested(69,321)$41.59 
Forfeited and other(3,641)$48.34 
Nonvested restricted share units at December 31, 2021128,171 $47.87